Darzalex (daratumumab)

• Your permanent residence is outside the European Union
• You take the medicines with you, unused within 90 days after purchase
• You have a full original receipt (which we provide you)

Unfortunately, we are unable to help with VAT refunds following delivery or collection from our partner pharmacies outside of the Netherlands.

• If you are residing within the European Union and you are not a company
• If you are coming to Amsterdam, Luxembourg or Dusseldorf to pick up your order

In case of pick up, you may be eligible for a VAT tax refund if you live outside the European Union.

• That you want to import an approved medicine from abroad
• The lack of reasonable treatment options available in your country (if you can, include a letter from a doctor confirming this) - no alternative to the treatment.
• That the medicine has already been approved in another country (state the name of the country)
• That your treating doctor states that this medicine is the best option for you (include a copy of the prescription in the letter to the healthcare insurance company)

• Name of the patient
• Contact details of patient(email and phone number)
• Copy of patient’s ID
• Contact details of the Doctor (name, address, email and phone number)
• Shipping address
• Copy of the doctor's prescription

Shipping: We can deliver to the patient's residence, a pharmacy, or doctor's office / hospital, but this depends on the country. If you’re not sure what the right choice is for you, please get in touch with our Patient Support Team and we can help you work out your exact requirements.

Once we have received this information, one of our Patient Support Team members will then check your prescription and contact you to follow up on your order. Please note that other documents may be needed for import, we will guide you through the ordering process.

Generally not, but we do provide you with an invoice after you make the payment that you may send to your medical insurance company so they can reimburse you. In some limited circumstances, we do accept insurance. Contact us for more details.

As part of our protocols we might reach out to your treating doctor for verification or information updates. By sending us your prescription you allow us to do so.

• Patient's name and date of birth
• Name of the medicine and dosage
• Required quantity
• Doctor's name and signature
• Doctor's registration number and/or stamp

Ideally, the prescription should be issued in English. Alternatively, a translation (unofficial is sufficient) must be provided.

Please be aware that your doctor may be contacted by one of our team members or by the processing pharmacy in order to verify the prescription.

• Copy of the ID/passport of the patient
• Copy of the ID/passport of the person who is coming to pick up the medicines
• Letter signed by the patient stating that he/she authorises this person to pick up the medicines on his/her behalf

1. Step 1 - Customs may need to check the package to verify its contents. In order to streamline this step, we include a letter for customs with information about the contents. Any additional questions will be answered by everyone.org as and when we are contacted by customs.
2. Step 2 - In some countries, there are additional questions from the medical regulatory agencies (i.e. the FDA, EMA, etc). We provide them with all the necessary information based on the information provided by the patient, such as: the prescription, copy of ID and a letter from the treating doctor to show that the medicines are for personal use.
3. Step 3 - Customs fees. In some cases, the recipient will be requested to pay taxes and duties. These should be arranged by the patient or receiver and are not covered by everyone.org unless stated otherwise.

Please be aware that the import of the medicines always requires customs clearance and active cooperation from the importing party. We will help and guide you but are dependent on your cooperation and responsiveness.

• Complete the enquiry form on our Contact Us page
• Send an email: [email protected]
• Call us on:
  • +31 20 808 4414 (EU)
  • +1 646 381 0675 (US)
  • +61 28 417 2910 (AUS)

The respective national and regional agencies, such as the Food and Drugs Administration (FDA) in the USA or the European Medical Authority (EMA) for the European Union assess these applications and make a decision on whether to approve new medicines. The review process is based on evaluation of the evidence provided by the company. Every agency uses a slightly different process.

1. Phase I - performed in a small number of healthy volunteers or very sick patients with lack of treatment options, designed to study the effects of the medicine in the human body.
2. Phase II - larger number of patients, designed to evaluate the safety and efficacy of the medicine and to determine if different dosages of the treatment have different effects.
3. Phase III - large number of patient groups, designed to confirm the safety and efficacy of the medicine.
4. Phase IV - after the medicine has received regulatory approval, designed to evaluate the long-term effects.